Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06538376 · ClinicalTrials.gov registry record · NA

Clinical Utility of Portable Dynamic Chest X Ray (DDR) in the ICU

A NA study of Pulmonary Embolism and Pneumonia, sponsored by Brigham and Women's Hospital.

Recruiting
Registry status
NA
Development phase
230
Enrollment target
1
Study location

NCT06538376: Recruiting NA study of Pulmonary Embolism and Pneumonia, sponsored by Brigham and Women's Hospital.

NCT06538376 is a NA study of Pulmonary Embolism and Pneumonia that is actively recruiting participants, run by Brigham and Women's Hospital. The registered enrollment target is 230 participants, below the 3,054-participant average among 48 other Pulmonary Embolism trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06538376, a NA study of Pulmonary Embolism and Pneumonia, is actively recruiting participants, sponsored by Brigham and Women's Hospital.

RECRUITING
Registry status
NA
Development phase
230 participants
Enrollment target
1
Study location

Study Summary

Dynamic digital radiography (DDR) is a new advanced version of chest radiography that captures dynamic images at a rate of 15 frames per second. It is coupled with an analytical software that allows it to provide more advanced measures of lung motion, ventilation, and perfusion compared to traditional chest radiography. While implementation of DDR fixed machines are beginning elsewhere in the US, this trial involves the first applications of an FDA-approved portable DDR machine, for use at the bedside in the ICU. The goal of this clinical trial is to determine the feasibility and safety of portable DDR technology in the ICU, as well as to evaluate the improved clinical diagnostic value of the portable DDR system over current standards of care. Participants will receive one to three sets of DDR images, which will then be compared to their clinical gold standard exams (such as chest x-rays, CTs, or VQ scans) to assess and improve the precision and accuracy of measurements such as diaphragmatic motion, lung movement, and perfusion.

Primary Outcome

Hypothesis: The Portable DDR technology can improve the visualization of parameters associated with lung physiology for ICU patients (diaphragmatic motion, lung motion) compared to current standards of care for imaging. Aim I-1: Determine the diagnostic precision of Portable DDR technology vs. routine standard of care imaging for specific lung pathologies (for example in pre- and post-transplant patients) that affect the mentioned cardiopulmonary functions. The DDR's precision will be measured

Interventions

  • DIAGNOSTIC_TEST Portable Dynamic Digital Radiography (DDR)

Study Locations (1)

Massachusetts

  • Brigham and Women's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 230 participants
Start Date 2023-12-12
Est. Completion 2027-11
Phase NA
Brigham and Women's Hospital

937 total trials

What NCT06538376 shows while recruiting

NCT06538376 is an interventional study that assigns participants to a tested intervention. The registered 230 participants enrollment target is mid-sized for trials with a published cap, below the 3,054-participant average among 48 other Pulmonary Embolism trials with a reported enrollment target (92% lower).

The record links to 10 conditions, with Pulmonary Embolism appearing as the primary indexed condition, and to 1 intervention - of which Portable Dynamic Digital Radiography (DDR) is the first listed.

NCT06538376 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06538376 about?

NCT06538376 is a clinical study titled "Clinical Utility of Portable Dynamic Chest X Ray (DDR) in the ICU". Dynamic digital radiography (DDR) is a new advanced version of chest radiography that captures dynamic images at a rate of 15 frames per second. It is coupled with an analytical software that allows it to provide more advanced measures of lung motion, ventilation, and perfusion compared to tradition...

What is the current status of trial NCT06538376?

This trial is currently recruiting. It is a NA study. The enrollment target is 230 participants. The study started on 2023-12-12. Estimated completion is 2027-11.

What conditions does trial NCT06538376 study?

This clinical trial studies the following conditions: Pulmonary Embolism, Pneumonia, Rib Fractures, Pleural Effusion, Airway Obstruction.

What interventions are being tested in trial NCT06538376?

The interventions under investigation include: Portable Dynamic Digital Radiography (DDR) (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT06538376?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06538376 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pulmonary Embolism

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06538376's enrollment target sits among peer trials

230 23rd of 48 higher than 26 of 48 other Pulmonary Embolism trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pulmonary Embolism trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02710253 · 230 participants · Phase 2

    Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy

  • NCT02777879 · 230 participants

    Lung Microbiome and Inflammation in Early COPD

  • NCT03824483 · 230 participants · Phase 2

    Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)

  • NCT03833622 · 230 participants · NA

    Shared Decision Making to Improve Goals of Care in the ED

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06538376, the US trial registry maintained by the National Library of Medicine. NCT06538376 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.